Legal Representation
Attorney
Belinda I. Berman
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 3, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 17, 2002 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 12, 2002 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 16, 2002 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 20, 2001 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 10, 2001 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 17, 2001 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 4, 2001 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 20, 2000 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 6, 2000 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Oct 6, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 15, 2000 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 10, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 28, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular conditions, epilepsy, mood disorders, pain, anxiety, cancer, auto-immune deficiency and diabetes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005